86 related articles for article (PubMed ID: 23495909)
21. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
22. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
23. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
24. Assay technologies for screening ion channel targets.
Mattheakis LC; Savchenko A
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
[TBL] [Abstract][Full Text] [Related]
25. Design of chemical libraries for screening.
Villar HO; Hansen MR
Expert Opin Drug Discov; 2009 Dec; 4(12):1215-20. PubMed ID: 23480462
[TBL] [Abstract][Full Text] [Related]
26. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
27. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional polymer scaffolds for high throughput cell-based assay systems.
Cheng K; Lai Y; Kisaalita WS
Biomaterials; 2008 Jun; 29(18):2802-12. PubMed ID: 18405966
[TBL] [Abstract][Full Text] [Related]
29. Oncology drug discovery applications using the FMAT 8100 HTS system.
Lee JY; Miraglia S; Yan X; Swartzman E; Cornell-Kennon S; Mellentin-Michelotti J; Bruseo C; France DS
J Biomol Screen; 2003 Feb; 8(1):81-8. PubMed ID: 12855001
[TBL] [Abstract][Full Text] [Related]
30. 2D and 3D cell microarrays in pharmacology.
Gidrol X; Fouqué B; Ghenim L; Haguet V; Picollet-D'hahan N; Schaack B
Curr Opin Pharmacol; 2009 Oct; 9(5):664-8. PubMed ID: 19520607
[TBL] [Abstract][Full Text] [Related]
31. Hypothesis testing in high-throughput screening for drug discovery.
Prummer M
J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
[TBL] [Abstract][Full Text] [Related]
32. Quantum dot-based screening system for discovery of g protein-coupled receptor agonists.
Lee J; Kwon YJ; Choi Y; Kim HC; Kim K; Kim J; Park S; Song R
Chembiochem; 2012 Jul; 13(10):1503-8. PubMed ID: 22692979
[TBL] [Abstract][Full Text] [Related]
33. Enzyme fragment complementation: a flexible high throughput screening assay technology.
Eglen RM
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):97-104. PubMed ID: 15090161
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines.
Lai Y; Asthana A; Kisaalita WS
Drug Discov Today; 2011 Apr; 16(7-8):293-7. PubMed ID: 21277382
[TBL] [Abstract][Full Text] [Related]
35. A fluorescent ligand-binding alternative using Tag-lite® technology.
Zwier JM; Roux T; Cottet M; Durroux T; Douzon S; Bdioui S; Gregor N; Bourrier E; Oueslati N; Nicolas L; Tinel N; Boisseau C; Yverneau P; Charrier-Savournin F; Fink M; Trinquet E
J Biomol Screen; 2010 Dec; 15(10):1248-59. PubMed ID: 20974902
[TBL] [Abstract][Full Text] [Related]
36. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
Liu H; Gao ZB; Yao Z; Zheng S; Li Y; Zhu W; Tan X; Luo X; Shen J; Chen K; Hu GY; Jiang H
J Med Chem; 2007 Jan; 50(1):83-93. PubMed ID: 17201412
[TBL] [Abstract][Full Text] [Related]
37. Strategies to generate biological reagents for kinase drug discovery.
Hassan NJ; Gul S
Expert Opin Drug Discov; 2011 Dec; 6(12):1215-25. PubMed ID: 22647062
[TBL] [Abstract][Full Text] [Related]
38. How can high-throughput screening deliver drugs to treat atherosclerosis?
Yang Y; Wang L; Si S; Hong B
Expert Opin Drug Discov; 2010 Dec; 5(12):1175-88. PubMed ID: 22822720
[TBL] [Abstract][Full Text] [Related]
39. Advances in functional assays for high-throughput screening of ion channels targets.
Trivedi S; Liu J; Liu R; Bostwick R
Expert Opin Drug Discov; 2010 Oct; 5(10):995-1006. PubMed ID: 22823991
[TBL] [Abstract][Full Text] [Related]
40. Improving consistency of cell-based assays by using division-arrested cells.
Fursov N; Cong M; Federici M; Platchek M; Haytko P; Tacke R; Livelli T; Zhong Z
Assay Drug Dev Technol; 2005 Feb; 3(1):7-15. PubMed ID: 15798391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
